U.S. PHYSICAL THERAPY INC (USPH)
US90337L1089 - Common Stock
Overall USPH gets a fundamental rating of 5 out of 10. We evaluated USPH against 118 industry peers in the Health Care Providers & Services industry. While USPH has a great health rating, its profitability is only average at the moment. USPH is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
USPH had positive earnings in the past year.
In the past year USPH had a positive cash flow from operations.
Each year in the past 5 years USPH has been profitable.
In the past 5 years USPH always reported a positive cash flow from operatings.
1.2 Ratios
USPH's Return On Assets of 1.73% is fine compared to the rest of the industry. USPH outperforms 64.96% of its industry peers.
USPH's Return On Equity of 3.68% is fine compared to the rest of the industry. USPH outperforms 68.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.61%, USPH is in the better half of the industry, outperforming 64.10% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for USPH is in line with the industry average of 8.65%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 3.68% | ||
| ROIC | 5.61% |
ROA(3y)3.13%
ROA(5y)4.06%
ROE(3y)7.87%
ROE(5y)9.63%
ROIC(3y)6.88%
ROIC(5y)7.92%
1.3 Margins
Looking at the Profit Margin, with a value of 2.88%, USPH is in the better half of the industry, outperforming 71.79% of the companies in the same industry.
In the last couple of years the Profit Margin of USPH has declined.
USPH has a better Operating Margin (10.94%) than 87.18% of its industry peers.
USPH's Operating Margin has declined in the last couple of years.
USPH has a worse Gross Margin (19.45%) than 64.10% of its industry peers.
In the last couple of years the Gross Margin of USPH has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.94% | ||
| PM (TTM) | 2.88% | ||
| GM | 19.45% |
OM growth 3Y-4.75%
OM growth 5Y-2.84%
PM growth 3Y-26.38%
PM growth 5Y-3.89%
GM growth 3Y-4.77%
GM growth 5Y-2.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USPH is destroying value.
USPH has more shares outstanding than it did 1 year ago.
USPH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, USPH has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.06 indicates that USPH is not in any danger for bankruptcy at the moment.
USPH has a better Altman-Z score (3.06) than 73.50% of its industry peers.
The Debt to FCF ratio of USPH is 2.21, which is a good value as it means it would take USPH, 2.21 years of fcf income to pay off all of its debts.
USPH has a Debt to FCF ratio of 2.21. This is amongst the best in the industry. USPH outperforms 87.18% of its industry peers.
A Debt/Equity ratio of 0.29 indicates that USPH is not too dependend on debt financing.
USPH has a Debt to Equity ratio of 0.29. This is in the better half of the industry: USPH outperforms 68.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | 3.06 |
ROIC/WACC0.65
WACC8.62%
2.3 Liquidity
USPH has a Current Ratio of 2.16. This indicates that USPH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.16, USPH is in the better half of the industry, outperforming 79.49% of the companies in the same industry.
USPH has a Quick Ratio of 2.16. This indicates that USPH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.16, USPH belongs to the top of the industry, outperforming 81.20% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.16 | ||
| Quick Ratio | 2.16 |
3. Growth
3.1 Past
USPH shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.42%.
The Earnings Per Share has been decreasing by -0.61% on average over the past years.
The Revenue has been growing slightly by 7.36% in the past year.
USPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.91% yearly.
EPS 1Y (TTM)-6.42%
EPS 3Y-3.51%
EPS 5Y-0.61%
EPS growth Q2Q-13.56%
Revenue 1Y (TTM)7.36%
Revenue growth 3Y12.66%
Revenue growth 5Y5.91%
Revenue growth Q2Q4.83%
3.2 Future
USPH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.51% yearly.
The Revenue is expected to grow by 6.14% on average over the next years.
EPS Next Y10.57%
EPS Next 2Y10.96%
EPS Next 3Y11.51%
EPS Next 5YN/A
Revenue Next Year6.13%
Revenue Next 2Y5.6%
Revenue Next 3Y6.14%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 43.54, which means the current valuation is very expensive for USPH.
USPH's Price/Earnings ratio is in line with the industry average.
USPH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.91.
The Price/Forward Earnings ratio is 34.26, which means the current valuation is very expensive for USPH.
USPH's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of USPH to the average of the S&P500 Index (20.51), we can say USPH is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.54 | ||
| Fwd PE | 34.26 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of USPH is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 70.94% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.66 | ||
| EV/EBITDA | 19.5 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USPH does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.12
PEG (5Y)N/A
EPS Next 2Y10.96%
EPS Next 3Y11.51%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.65%, USPH has a reasonable but not impressive dividend return.
USPH's Dividend Yield is rather good when compared to the industry average which is at 2.74. USPH pays more dividend than 90.60% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.34, USPH is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.65% |
5.2 History
On average, the dividend of USPH grows each year by 13.34%, which is quite nice.
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)13.34%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
136.73% of the earnings are spent on dividend by USPH. This is not a sustainable payout ratio.
The dividend of USPH is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP136.73%
EPS Next 2Y10.96%
EPS Next 3Y11.51%
U.S. PHYSICAL THERAPY INC
NYSE:USPH (5/15/2024, 5:30:00 PM)
After market: 107.97 0 (0%)107.97
+1.57 (+1.48%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.63B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.65% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.54 | ||
| Fwd PE | 34.26 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.12
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.73% | ||
| ROE | 3.68% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 10.94% | ||
| PM (TTM) | 2.88% | ||
| GM | 19.45% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.16 | ||
| Quick Ratio | 2.16 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-6.42%
EPS 3Y-3.51%
EPS 5Y
EPS growth Q2Q
EPS Next Y10.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)7.36%
Revenue growth 3Y12.66%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y